These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 17726536)

  • 1. Primary role of functional ischemia, quantitative evidence for the two-hit mechanism, and phosphodiesterase-5 inhibitor therapy in mouse muscular dystrophy.
    Asai A; Sahani N; Kaneki M; Ouchi Y; Martyn JA; Yasuhara SE
    PLoS One; 2007 Aug; 2(8):e806. PubMed ID: 17726536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphodiesterase 4 inhibitor and phosphodiesterase 5 inhibitor combination therapy has antifibrotic and anti-inflammatory effects in mdx mice with Duchenne muscular dystrophy.
    Nio Y; Tanaka M; Hirozane Y; Muraki Y; Okawara M; Hazama M; Matsuo T
    FASEB J; 2017 Dec; 31(12):5307-5320. PubMed ID: 28798156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tadalafil alleviates muscle ischemia in patients with Becker muscular dystrophy.
    Martin EA; Barresi R; Byrne BJ; Tsimerinov EI; Scott BL; Walker AE; Gurudevan SV; Anene F; Elashoff RM; Thomas GD; Victor RG
    Sci Transl Med; 2012 Nov; 4(162):162ra155. PubMed ID: 23197572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment with a nitric oxide-donating NSAID alleviates functional muscle ischemia in the mouse model of Duchenne muscular dystrophy.
    Thomas GD; Ye J; De Nardi C; Monopoli A; Ongini E; Victor RG
    PLoS One; 2012; 7(11):e49350. PubMed ID: 23139842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AMPK activation stimulates autophagy and ameliorates muscular dystrophy in the mdx mouse diaphragm.
    Pauly M; Daussin F; Burelle Y; Li T; Godin R; Fauconnier J; Koechlin-Ramonatxo C; Hugon G; Lacampagne A; Coisy-Quivy M; Liang F; Hussain S; Matecki S; Petrof BJ
    Am J Pathol; 2012 Aug; 181(2):583-92. PubMed ID: 22683340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Common micro-RNA signature in skeletal muscle damage and regeneration induced by Duchenne muscular dystrophy and acute ischemia.
    Greco S; De Simone M; Colussi C; Zaccagnini G; Fasanaro P; Pescatori M; Cardani R; Perbellini R; Isaia E; Sale P; Meola G; Capogrossi MC; Gaetano C; Martelli F
    FASEB J; 2009 Oct; 23(10):3335-46. PubMed ID: 19528256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. X-irradiation improves mdx mouse muscle as a model of myofiber loss in DMD.
    Wakeford S; Watt DJ; Partridge TA
    Muscle Nerve; 1991 Jan; 14(1):42-50. PubMed ID: 1992296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Smooth muscle-specific dystrophin expression improves aberrant vasoregulation in mdx mice.
    Ito K; Kimura S; Ozasa S; Matsukura M; Ikezawa M; Yoshioka K; Ueno H; Suzuki M; Araki K; Yamamura K; Miwa T; Dickson G; Thomas GD; Miike T
    Hum Mol Genet; 2006 Jul; 15(14):2266-75. PubMed ID: 16777842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Divergent impact of Toll-like receptor 2 deficiency on repair mechanisms in healthy muscle versus Duchenne muscular dystrophy.
    Mojumdar K; Giordano C; Lemaire C; Liang F; Divangahi M; Qureshi ST; Petrof BJ
    J Pathol; 2016 May; 239(1):10-22. PubMed ID: 26800321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic administration of IGF-I enhances oxidative status and reduces contraction-induced injury in skeletal muscles of mdx dystrophic mice.
    Schertzer JD; Ryall JG; Lynch GS
    Am J Physiol Endocrinol Metab; 2006 Sep; 291(3):E499-505. PubMed ID: 16621899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The anticancer drug tamoxifen counteracts the pathology in a mouse model of duchenne muscular dystrophy.
    Dorchies OM; Reutenauer-Patte J; Dahmane E; Ismail HM; Petermann O; Patthey- Vuadens O; Comyn SA; Gayi E; Piacenza T; Handa RJ; Décosterd LA; Ruegg UT
    Am J Pathol; 2013 Feb; 182(2):485-504. PubMed ID: 23332367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological activation of PPARbeta/delta stimulates utrophin A expression in skeletal muscle fibers and restores sarcolemmal integrity in mature mdx mice.
    Miura P; Chakkalakal JV; Boudreault L; Bélanger G; Hébert RL; Renaud JM; Jasmin BJ
    Hum Mol Genet; 2009 Dec; 18(23):4640-9. PubMed ID: 19744959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The mdx mouse diaphragm reproduces the degenerative changes of Duchenne muscular dystrophy.
    Stedman HH; Sweeney HL; Shrager JB; Maguire HC; Panettieri RA; Petrof B; Narusawa M; Leferovich JM; Sladky JT; Kelly AM
    Nature; 1991 Aug; 352(6335):536-9. PubMed ID: 1865908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted expression of insulin-like growth factor-I reduces early myofiber necrosis in dystrophic mdx mice.
    Shavlakadze T; White J; Hoh JF; Rosenthal N; Grounds MD
    Mol Ther; 2004 Nov; 10(5):829-43. PubMed ID: 15509501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inspiratory loading does not accelerate dystrophy in mdx mouse diaphragm: implications for regenerative therapy.
    Krupnick AS; Zhu J; Nguyen T; Kreisel D; Balsara KR; Lankford EB; Clark CC; Levine S; Stedman HH; Shrager JB
    J Appl Physiol (1985); 2003 Feb; 94(2):411-9. PubMed ID: 12531909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment with human immunoglobulin G improves the early disease course in a mouse model of Duchenne muscular dystrophy.
    Zschüntzsch J; Zhang Y; Klinker F; Makosch G; Klinge L; Malzahn D; Brinkmeier H; Liebetanz D; Schmidt J
    J Neurochem; 2016 Jan; 136(2):351-62. PubMed ID: 26230042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Shifts in macrophage phenotypes and macrophage competition for arginine metabolism affect the severity of muscle pathology in muscular dystrophy.
    Villalta SA; Nguyen HX; Deng B; Gotoh T; Tidball JG
    Hum Mol Genet; 2009 Feb; 18(3):482-96. PubMed ID: 18996917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GLPG0492, a novel selective androgen receptor modulator, improves muscle performance in the exercised-mdx mouse model of muscular dystrophy.
    Cozzoli A; Capogrosso RF; Sblendorio VT; Dinardo MM; Jagerschmidt C; Namour F; Camerino GM; De Luca A
    Pharmacol Res; 2013 Jun; 72():9-24. PubMed ID: 23523664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined effect of AAV-U7-induced dystrophin exon skipping and soluble activin Type IIB receptor in mdx mice.
    Hoogaars WM; Mouisel E; Pasternack A; Hulmi JJ; Relizani K; Schuelke M; Schirwis E; Garcia L; Ritvos O; Ferry A; 't Hoen PA; Amthor H
    Hum Gene Ther; 2012 Dec; 23(12):1269-79. PubMed ID: 22894762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanical Overloading Increases Maximal Force and Reduces Fragility in Hind Limb Skeletal Muscle from Mdx Mouse.
    Ferry A; Parlakian A; Joanne P; Fraysse B; Mgrditchian T; Roy P; Furling D; Butler-Browne G; Agbulut O
    Am J Pathol; 2015 Jul; 185(7):2012-24. PubMed ID: 26009153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.